Citadel Advisors
PPH icon

Citadel Advisors’s VanEck Pharmaceutical ETF PPH Stock Holding History

Citadel Advisors’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.97M Buy
+67,086
New +$7.15M ﹤0.01% 3816
2025
Q4 		– Sell
-56,184
Closed -$5.47M – 13756
2025
Q3 		$5.08M Buy
56,184
+24,907
+80% +$2.18M ﹤0.01% 4337
2025
Q2 		$2.75M Sell
31,277
-10,135
-24% -$879K ﹤0.01% 5123
2025
Q1 		$3.77M Buy
41,412
+12,875
+45% +$1.16M ﹤0.01% 4355
2024
Q4 		$2.46M Sell
28,537
-35,813
-56% -$3.24M ﹤0.01% 5204
2024
Q3 		$6.12M Buy
+64,350
New +$6.11M ﹤0.01% 3634
2024
Q2 		– Sell
-53,227
Closed -$4.75M – 15130
2024
Q1 		$4.83M Buy
53,227
+4,051
+8% +$355K ﹤0.01% 4003
2023
Q4 		$4M Buy
49,176
+24,656
+101% +$1.93M ﹤0.01% 4124
2023
Q3 		$1.96M Sell
24,520
-12,913
-34% -$1.04M ﹤0.01% 5255
2023
Q2 		$2.95M Buy
37,433
+11,920
+47% +$933K ﹤0.01% 4504
2023
Q1 		$1.98M Sell
25,513
-4,808
-16% -$371K ﹤0.01% 5391
2022
Q4 		$2.36M Sell
30,321
-31,239
-51% -$2.3M ﹤0.01% 5170
2022
Q3 		$4.14M Buy
+61,560
New +$4.53M ﹤0.01% 4190
2022
Q2 		– Sell
-12,120
Closed -$946K – 13826
2022
Q1 		$967K Sell
12,120
-23,395
-66% -$1.79M ﹤0.01% 7775
2021
Q4 		$2.73M Sell
35,515
-13,500
-28% -$1M ﹤0.01% 5521
2021
Q3 		$3.56M Sell
49,015
-16,013
-25% -$1.19M ﹤0.01% 4984
2021
Q2 		$4.75M Buy
65,028
+7,279
+13% +$519K ﹤0.01% 4555
2021
Q1 		$3.99M Buy
57,749
+39,171
+211% +$2.7M ﹤0.01% 4764
2020
Q4 		$1.24M Sell
18,578
-45,035
-71% -$2.89M ﹤0.01% 6345
2020
Q3 		$3.96M Buy
63,613
+25,616
+67% +$1.62M ﹤0.01% 3507
2020
Q2 		$2.37M Sell
37,997
-3,197
-8% -$193K ﹤0.01% 4282
2020
Q1 		$2.24M Sell
41,194
-7,075
-15% -$436K ﹤0.01% 3950
2019
Q4 		$3.1M Sell
48,269
-808
-2% -$48.7K ﹤0.01% 3739
2019
Q3 		$2.79M Sell
49,077
-12,689
-21% -$727K ﹤0.01% 3962
2019
Q2 		$3.62M Buy
61,766
+38,920
+170% +$2.25M ﹤0.01% 3565
2019
Q1 		$1.39M Sell
22,846
-57,258
-71% -$3.38M ﹤0.01% 5036
2018
Q4 		$4.41M Buy
80,104
+56,569
+240% +$3.43M ﹤0.01% 2964
2018
Q3 		$1.51M Sell
23,535
-25,894
-52% -$1.61M ﹤0.01% 4860
2018
Q2 		$2.92M Buy
49,429
+29,951
+154% +$1.74M ﹤0.01% 3520
2018
Q1 		$1.1M Buy
19,478
+1,966
+11% +$117K ﹤0.01% 4672
2017
Q4 		$1.04M Sell
17,512
-998
-5% -$57.2K ﹤0.01% 4600
2017
Q3 		$1.07M Sell
18,510
-2,343
-11% -$133K ﹤0.01% 4221
2017
Q2 		$1.23M Buy
20,853
+6,141
+42% +$347K ﹤0.01% 3800
2017
Q1 		$811K Sell
14,712
-8,463
-37% -$459K ﹤0.01% 4301
2016
Q4 		$1.22M Sell
23,175
-22,671
-49% -$1.21M ﹤0.01% 3593
2016
Q3 		$2.63M Buy
45,846
+37,801
+470% +$2.27M ﹤0.01% 2645
2016
Q2 		$471K Buy
8,045
+1,914
+31% +$112K ﹤0.01% 4566
2016
Q1 		$352K Sell
6,131
-181
-3% -$10.7K ﹤0.01% 4889
2015
Q4 		$412K Sell
6,312
-4,409
-41% -$285K ﹤0.01% 4738
2015
Q3 		$675K Buy
10,721
+69
+0.6% +$4.85K ﹤0.01% 4361
2015
Q2 		$754K Buy
10,652
+4,197
+65% +$302K ﹤0.01% 4363
2015
Q1 		$453K Sell
6,455
-10,469
-62% -$710K ﹤0.01% 5044
2014
Q4 		$1.09M Buy
16,924
+16,034
+1,802% +$1.02M ﹤0.01% 3667
2014
Q3 		$57K Sell
890
-1,455
-62% -$90.1K ﹤0.01% 6819
2014
Q2 		$145K Sell
2,345
-6,380
-73% -$379K ﹤0.01% 5897
2014
Q1 		$510K Buy
+8,725
New +$493K ﹤0.01% 4320

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
BCIM
British Columbia Investment Management Victoria, British Columbia, Canada $17B AUM 31.69% 1-Year Est. Return
ERSOT
Employees Retirement System of Texas Austin, Texas $11.4B AUM 21.6% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
JSAM
J. Safra Asset Management New York $1.86B AUM 22.95% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
AT
Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return

Citadel Advisors's PPH Position: Q1 2026 in Review

Citadel Advisors opened a new position in VanEck Pharmaceutical ETF (PPH) in Q1 2026: 67,086 shares worth $6.97M. The stake represents ﹤0.01% of the portfolio and ranks #3816 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in PPH as recently as Q3 2025.

Citadel Advisors first reported a position in PPH in Q1 2014 and has held it in 46 quarters since. 147 funds tracked by Wall St. Rank hold PPH as of Q1 2026.

  • Citadel Advisors held 67,086 shares of VanEck Pharmaceutical ETF worth $6.97M as of Q1 2026.
  • VanEck Pharmaceutical ETF was a new Citadel Advisors position in Q1 2026.
  • VanEck Pharmaceutical ETF made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #3816 holding.
  • Citadel Advisors first reported a position in VanEck Pharmaceutical ETF in Q1 2014 and has held it in 46 quarters since.
  • 147 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.